Airway Remodeling
Conditions
Keywords
laryngeal mask, airway leakage, airway morbidity
Brief summary
In a observational study the second-generation laryngeal masks LMA Supreme and Ambu AuraGain are investigated.
Detailed description
After approval from the local ethics committee, data were collected in a prospective, non- randomised study over a three-month period. When contra-indications for laryngeal mask use were absent anaesthesiologists used either Supreme (Teleflex Medical GmbH, Germany) or Gain (Ambu GmbH, Germany). Endpoints were the success rate and time to insertion.
Interventions
Success rate and time for insertion
Sponsors
Study design
Eligibility
Inclusion criteria
* Age ≥ 18 Years * No concurrent participation in another study * capacity to consent * Present written informed consent of the research participant * Elective surgery under general anesthesia
Exclusion criteria
* Age \<18 years * Existing pregnancy * Lack of consent * inability to consent * emergency patients * Emergency situations in the context of a Difficult Airway Management * ASA classification\> 3 * situations where the possibility of accumulated gastric contents * Participation in another study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Success rate | 70-98 Percent | overall and first attempt success rate |
Secondary
| Measure | Time frame |
|---|---|
| Time for insertion | 5-120 seconds |
| Leakage in ml.min | 0-300 ml.min |
Countries
Germany